Literature DB >> 24030252

IGF-1R modulation of acute GH-induced STAT5 signaling: role of protein tyrosine phosphatase activity.

Yujun Gan1, Yue Zhang, Ashiya Buckels, Andrew J Paterson, Jing Jiang, Thomas L Clemens, Zhong-Yin Zhang, Keyong Du, Yingzi Chang, Stuart J Frank.   

Abstract

GH is a potent anabolic and metabolic factor that binds its cell surface receptor (GHR), activating the GHR-associated tyrosine kinase, Janus kinase 2, which phosphorylates and activates the latent transcription factor, signal transducer and activator of transcription 5 (STAT5). Some GH actions are mediated by the elaboration of IGF-1, which exerts effects by binding and activating the heterotetrameric tyrosine kinase growth factor receptor, IGF-1R. In addition to this GH-GHR-IGF-1-IGF-1R scheme, we have demonstrated in primary osteoblasts and in islet β-cells that then deletion or silencing of IGF-1R results in diminished GH-induced STAT5 phosphorylation, suggesting that the presence of IGF-1R may facilitate GH signaling. In this study, we explore potential roles for protein tyrosine phosphatase activity in modulating GH-induced signaling, comparing conditions in which IGF-1R is present or diminished. We confirm that in mouse primary osteoblasts harboring loxP sites flanking the IGF-1R gene, infection with an adenovirus that expresses the Cre recombinase results in IGF-1R deletion and diminished acute GH-induced STAT5 phosphorylation. Furthermore, we present a new model of IGF-1R silencing, in which expression of short hairpin RNA directed at IGF-1R greatly reduces IGF-1R abundance in LNCaP human prostate cancer cells. In both models, treatment with a chemical inhibitor of protein tyrosine phosphatase-1B (PTP-1B), but not one of src homology region 2 domain-containing phosphotase-1 (SHP-1) and SHP-2, reverses the loss of GH-induced STAT5 phosphorylation in cells lacking IGF-1R but has no effect in cells with intact IGF-1R. Furthermore, expression of either a dominant-negative PTP-1B or the PTP-1B-interacting inhibitory protein, constitutive photomorphogenesis 1, also rescues acute GH-induced STAT5 signaling in IGF-1R-deficient cells but has no effect in IGF-1R replete cells. By expressing a substrate-trapping mutant PTP-1B, we demonstrate that tyrosine phosphorylated Janus kinase-2 is a PTP-1B substrate only in cells lacking IGF-1R. Collectively, our data suggest that IGF-1R positively regulates acute GH signaling by preventing access of PTP-1B activity to Janus kinase 2 and thereby preventing PTP-1B-mediated suppression of GH-induced STAT5 activation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24030252      PMCID: PMC3805849          DOI: 10.1210/me.2013-1178

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  53 in total

Review 1.  PTP1B: from the sidelines to the front lines!

Authors:  Nicholas K Tonks
Journal:  FEBS Lett       Date:  2003-07-03       Impact factor: 4.124

2.  Acute control of insulin-like growth factor-I gene transcription by growth hormone through Stat5b.

Authors:  Joachim Woelfle; Julia Billiard; Peter Rotwein
Journal:  J Biol Chem       Date:  2003-04-07       Impact factor: 5.157

Review 3.  Distinct and overlapping functions of insulin and IGF-I receptors.

Authors:  J Nakae; Y Kido; D Accili
Journal:  Endocr Rev       Date:  2001-12       Impact factor: 19.871

4.  STAT5b is required for GH-induced liver IGF-I gene expression.

Authors:  H W Davey; T Xie; M J McLachlan; R J Wilkins; D J Waxman; D R Grattan
Journal:  Endocrinology       Date:  2001-09       Impact factor: 4.736

5.  Allosteric inhibition of protein tyrosine phosphatase 1B.

Authors:  Christian Wiesmann; Kenneth J Barr; Jenny Kung; Jiang Zhu; Daniel A Erlanson; Wang Shen; Bruce J Fahr; Min Zhong; Lisa Taylor; Mike Randal; Robert S McDowell; Stig K Hansen
Journal:  Nat Struct Mol Biol       Date:  2004-07-18       Impact factor: 15.369

6.  Protein tyrosine phosphatase 1B attenuates growth hormone-mediated JAK2-STAT signaling.

Authors:  Feng Gu; Nadia Dubé; Jin Wook Kim; Alan Cheng; Maria de Jesus Ibarra-Sanchez; Michel L Tremblay; Yves R Boisclair
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

7.  NO attenuates insulin signaling and motility in aortic smooth muscle cells via protein tyrosine phosphatase 1B-mediated mechanism.

Authors:  Nair Sreejayan; Yi Lin; Aviv Hassid
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-07-01       Impact factor: 8.311

8.  Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization.

Authors:  Mei Zhang; Shouhong Xuan; Mary L Bouxsein; Dietrich von Stechow; Nagako Akeno; Marie Claude Faugere; Hartmut Malluche; Guisheng Zhao; Clifford J Rosen; Argiris Efstratiadis; Thomas L Clemens
Journal:  J Biol Chem       Date:  2002-09-04       Impact factor: 5.157

9.  Physical and functional interaction of growth hormone and insulin-like growth factor-I signaling elements.

Authors:  Yao Huang; Sung-Oh Kim; Ning Yang; Jing Jiang; Stuart J Frank
Journal:  Mol Endocrinol       Date:  2004-03-25

10.  Identification of protein tyrosine phosphatases with specificity for the ligand-activated growth hormone receptor.

Authors:  Christian Pasquali; Marie-Laure Curchod; Sébastien Wälchli; Xavier Espanel; Mireille Guerrier; Fabrizio Arigoni; Ger Strous; Rob Hooft van Huijsduijnen
Journal:  Mol Endocrinol       Date:  2003-08-07
View more
  12 in total

1.  Growth hormone (GH) receptor (GHR)-specific inhibition of GH-Induced signaling by soluble IGF-1 receptor (sol IGF-1R).

Authors:  Yue Zhang; Sajina Gc; Sweta B Patel; Ying Liu; Andrew J Paterson; John C Kappes; Jing Jiang; Stuart J Frank
Journal:  Mol Cell Endocrinol       Date:  2019-05-14       Impact factor: 4.102

2.  DMP-1-mediated Ghr gene recombination compromises skeletal development and impairs skeletal response to intermittent PTH.

Authors:  Zhongbo Liu; Oran D Kennedy; Luis Cardoso; Jelena Basta-Pljakic; Nicola C Partridge; Mitchell B Schaffler; Clifford J Rosen; Shoshana Yakar
Journal:  FASEB J       Date:  2015-10-19       Impact factor: 5.191

3.  Human GH receptor-IGF-1 receptor interaction: implications for GH signaling.

Authors:  Yujun Gan; Ashiya Buckels; Ying Liu; Yue Zhang; Andrew J Paterson; Jing Jiang; Kurt R Zinn; Stuart J Frank
Journal:  Mol Endocrinol       Date:  2014-09-11

Review 4.  Minireview: mechanisms of growth hormone-mediated gene regulation.

Authors:  Dennis J Chia
Journal:  Mol Endocrinol       Date:  2014-05-13

5.  Functional collaboration of insulin-like growth factor-1 receptor (IGF-1R), but not insulin receptor (IR), with acute GH signaling in mouse calvarial cells.

Authors:  Yujun Gan; Andrew J Paterson; Yue Zhang; Jing Jiang; Stuart J Frank
Journal:  Endocrinology       Date:  2013-01-01       Impact factor: 4.736

Review 6.  New Insights from IGF-IR Stimulating Activity Analyses: Pathological Considerations.

Authors:  Joseph A M J L Janssen
Journal:  Cells       Date:  2020-04-02       Impact factor: 6.600

Review 7.  Classical and novel GH receptor signaling pathways.

Authors:  Stuart J Frank
Journal:  Mol Cell Endocrinol       Date:  2020-08-22       Impact factor: 4.102

8.  Insulin-Like Growth Factors Are Key Regulators of T Helper 17 Regulatory T Cell Balance in Autoimmunity.

Authors:  Daniel DiToro; Stacey N Harbour; Jennifer K Bando; Gloria Benavides; Steven Witte; Vincent A Laufer; Carson Moseley; Jeffery R Singer; Blake Frey; Henrietta Turner; Jens Bruning; Victor Darley-Usmar; Min Gao; Cheryl Conover; Robin D Hatton; Stuart Frank; Marco Colonna; Casey T Weaver
Journal:  Immunity       Date:  2020-04-14       Impact factor: 31.745

Review 9.  The Growth Hormone Receptor: Mechanism of Receptor Activation, Cell Signaling, and Physiological Aspects.

Authors:  Farhad Dehkhoda; Christine M M Lee; Johan Medina; Andrew J Brooks
Journal:  Front Endocrinol (Lausanne)       Date:  2018-02-13       Impact factor: 5.555

10.  IGF-1 induces the epithelial-mesenchymal transition via Stat5 in hepatocellular carcinoma.

Authors:  Chuanzong Zhao; Qian Wang; Ben Wang; Qi Sun; Zhaobin He; Jianguo Hong; Florian Kuehn; Enyu Liu; Zongli Zhang
Journal:  Oncotarget       Date:  2017-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.